A highly-toxic protein described as the "real bad guy" behind Alzheimer's disease has been identified by scientists.
The molecule recruits other less harmful proteins and makes them deadly to brain cells.
Knowing how it forms and behaves is expected to lead to more effective Alzheimer's treatments.
One experimental drug to emerge from the research has already completed early phase I clinical trials. The protein is a special type of beta-amyloid, which was already known to play a key role in Alzheimer's.
Beta-amyloid clumps together in the brains of Alzheimer's patients, forming deposits that result in the destruction of nerve cells.
"This form of beta-amyloid, called pyroglutamylated (or pyroglu) beta-amyloid, is a real bad guy in Alzheimer's disease," said lead scientist Professor George Bloom, from the University of Virginia in the US.
"We've confirmed that it converts more abundant beta-amyloids into a form that is up to 100 times more toxic, making this a very dangerous killer of brain cells and an attractive target for drug therapy."
He compared the way the protein spread destruction in the brain to the transmission of prion diseases, such as Creutzfeldt Jakob Disease (CJD).
Prion diseases are caused by rogue misshapen proteins that toxify other proteins they come into contact with in a chain reaction.
"You might think of this pyroglu beta-amyloid as a seed that can further contaminate something that's already bad into something much worse - it's the trigger," said Prof Bloom.
The research is published today in the latest online edition of the journal Nature.
Prof Bloom's team also looked at interactions between beta-amyloid and tau, another Alzheimer's-related protein.
Mouse experiments confirmed that both beta-amyloid and tau were needed to trigger the destruction of nerve cells.
"There are two matters of practical importance in our discovery," said Prof Bloom.
"One is the new insights we have as to how Alzheimer's might actually progress - the mechanisms which are important to understand if we are to try to prevent it from happening; and second, it provides a lead into how to design drugs that might prevent this kind of beta-amyloid from building up in the first place."
Co-author Dr Hans-Ulrich Demuth, chief scientific officer at the German biotech company Probiodrug, said: "This publication further adds significant evidence to our hypothesis about the critical role pyroglu beta-amyloid plays in the initiation of Alzheimer's disease."
Probiodrug, based in Halle, has completed phase I safety trials of a drug that suppresses an enzyme involved in the formation of pyroglu beta-amyloid.
A study at Mount Sinai School of Medicine found that decaffeinated coffee improves the brain's energy metabolism - linked to cognitive decline - in those with Type 2 diabetes. "This is the first evidence showing the potential benefits of decaffeinated coffee preparations for both preventing and treating cognitive decline caused by type 2 diabetes, ageing, and/ or neurodegenerative disorders," said lead researcher, Dr Giulio Maria Pasinett.
Everyday games, puzzles and tasks were able to postpone decline in cognitive function and the ability to carry out everyday tasks, in dementia patients, for at least a year, according to research from the University of Erlangen in Germany, published in the journals BMC Medicine.
Eating fewer calories could help boost memory and cognitive function, according to a study at the Catholic University of the Sacred Heart in Rome. Researchers hope to mimic the same effect with a drug in the future, bringing hope to Alzheimer's sufferers as well as those suffering from injury-related memory loss.
Researchers at the University of Pittsburgh Medical Centre and School of Medicine found that people who ate baked or grilled fish regularly reduced their risk of developing Alzheimer's. Reseracher Cyrus Raji said: "The results showed that people who consumed baked or broiled (grilled) fish at least one time per week had better preservation of grey matter volume on MRI in brain areas at risk for Alzheimer's disease."
Working out using virtual games such as the Wii Fit could slow cognitive decline in the over 50s, researchers from Union College in the US found. Participants aged between 58 and 99 were given a 3D exercise game to play. Compared to the control group who were asked to use a regular exercise bike, the 'cybercycle' group had a 23% decrease in advancement of mild cognitive impairment and showed improved 'executive function'.
A study in The Lancet Neurology suggest that 3m cases of Alzheimer's across the world could be prevented in seven simple ways. The report recommends quitting smoking, increasing physical activity, controlling your blood pressure and diabetes risk factors as well as managing depression and obesity to help combat the disease.